Maspin has been characterized as a class II tumor suppressor based on its ability to inhibit cell invasion and angiogenesis and to promote apoptosis [48–50], suggesting maspin as a potential therapeutic target in multiple cancer types [51]. Here, SERPINB5 is linked to cancer.